Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Patients Seeking Sustained Weight Loss Before Transitioning Off Medication: A common patient concern is medication dependency needing to stay on semaglutide indefinitely to maintain results
- Injection-site inspection for redness, induration, or lipohypertrophy
The primary concern is additive nausea, as both medications list nausea as a common side effect
For context, semaglutide and tirzepatide typically see 4-7% discontinuation rates due to adverse events in their trials
Contacting us If you would like to contact us concerning any matter relating to this Refund Policy, you may do so via the contact form This document was last updated on July 2, 2021
US$ 28.25
US$ 22.99
US$ 25.65
US$ 21.14
US$ 25.32
